The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Immune Modulatory DC Vaccine Against Brain Tumor

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03914768
Recruitment Status : Unknown
Verified June 2020 by Shenzhen Geno-Immune Medical Institute.
Recruitment status was:  Enrolling by invitation
First Posted : April 16, 2019
Last Update Posted : June 12, 2020
Sponsor:
Collaborators:
Shenzhen Hospital of Southern Medical University
Shenzhen Children's Hospital
Information provided by (Responsible Party):
Shenzhen Geno-Immune Medical Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : January 31, 2021
Estimated Study Completion Date : December 31, 2022